Session

IBD (Posters)

USE OF TUMOR NECROSIS FACTOR-ALPHA ANTAGONISTS IS ASSOCIATED WITH ATTENUATED IGG ANTIBODY RESPONSE AGAINST SARS-COV-2 IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
USE OF TUMOR NECROSIS FACTOR-ALPHA ANTAGONISTS IS ASSOCIATED WITH ATTENUATED IGG ANTIBODY RESPONSE AGAINST SARS-COV-2 IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

DISTINCT MUCOSAL HOST-MICROBE INTERACTIONS IN RELATION TO CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE
DISTINCT MUCOSAL HOST-MICROBE INTERACTIONS IN RELATION TO CLINICAL PHENOTYPES IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES
MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

ESTIMATING LOCAL TNF MRNA LEVELS PRIOR TO ANTI-TNF-ALPHA TREATMENT MAY HELP THERAPEUTIC OPTIMIZATION IN CHILDREN WITH IBD
ESTIMATING LOCAL TNF MRNA LEVELS PRIOR TO ANTI-TNF-ALPHA TREATMENT MAY HELP THERAPEUTIC OPTIMIZATION IN CHILDREN WITH IBD

IBD (Posters)  et al.

EXPOSURE TO SYSTEMIC ANTIBIOTICS INCREASES THE RISK OF INFLAMMATORY BOWEL DISEASE IN A DOSE-DEPENDENT MANNER: A POPULATION-BASED CASE-CONTROL STUDY IN KOREA
EXPOSURE TO SYSTEMIC ANTIBIOTICS INCREASES THE RISK OF INFLAMMATORY BOWEL DISEASE IN A DOSE-DEPENDENT MANNER: A POPULATION-BASED CASE-CONTROL STUDY IN KOREA

IBD (Posters)  et al.

RESPONSIVENESS OF FECAL CALPROTECTIN AND QUALITY OF LIFE QUESTIONNAIRES TO CHANGE IN POUCH DISEASE ACTIVITY. RESULTS FROM A PROSPECTIVE TRIAL
RESPONSIVENESS OF FECAL CALPROTECTIN AND QUALITY OF LIFE QUESTIONNAIRES TO CHANGE IN POUCH DISEASE ACTIVITY. RESULTS FROM A PROSPECTIVE TRIAL

IBD (Posters)  et al.

MORTALITY IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES – A POPULATION-BASED STUDY FROM THE EPIDEMIOLOGICAL DATABASE OF THE ISRAELI IBD RESEARCH NUCLEUS (EPI-IIRN)
MORTALITY IN ELDERLY-ONSET INFLAMMATORY BOWEL DISEASES – A POPULATION-BASED STUDY FROM THE EPIDEMIOLOGICAL DATABASE OF THE ISRAELI IBD RESEARCH NUCLEUS (EPI-IIRN)

IBD (Posters)  et al.

CHARACTERIZATION OF THE CYTOKINE EXPRESSION IN HUMAN COLON ORGANOIDS FROM INFLAMMATORY BOWEL DISEASE PATIENTS
CHARACTERIZATION OF THE CYTOKINE EXPRESSION IN HUMAN COLON ORGANOIDS FROM INFLAMMATORY BOWEL DISEASE PATIENTS

IBD (Posters)  et al.

ELEVATED ADAPTIVE IMMUNE RESPONSES TO MULTIPLE LACHNOSPIRACEAE BACTERIAL FLAGELLINS IN THERAPY-NAIVE PEDIATRIC CD PATIENTS ARE ASSOCIATED WITH DISTINCT IMMUNE PATHOLOGY
ELEVATED ADAPTIVE IMMUNE RESPONSES TO MULTIPLE LACHNOSPIRACEAE BACTERIAL FLAGELLINS IN THERAPY-NAIVE PEDIATRIC CD PATIENTS ARE ASSOCIATED WITH DISTINCT IMMUNE PATHOLOGY

IBD (Posters)  et al.

PREVALENCE OF DISEASE RELATED MALNUTRITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTRIC CROSS-SECTIONAL STUDY
PREVALENCE OF DISEASE RELATED MALNUTRITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTRIC CROSS-SECTIONAL STUDY

IBD (Posters)  et al.

LATENT TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE CANDIDATES TO BIOLOGICS: PREVALENCE AND EFFECTIVENESS OF CHEMOPROPHYLAXIS
LATENT TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE CANDIDATES TO BIOLOGICS: PREVALENCE AND EFFECTIVENESS OF CHEMOPROPHYLAXIS

IBD (Posters)  et al.

DIFFERENTIAL EXPRESSION OF MIR-424-5P AND MIR-378C IN STENOTIC AND PENETRATING LESSIONS OF CROHN’S DISEASE ASSOCIATES WITH ALTERED TRANSCRIPTION OF GENES INVOLVED IN VASCULAR REGULATION
DIFFERENTIAL EXPRESSION OF MIR-424-5P AND MIR-378C IN STENOTIC AND PENETRATING LESSIONS OF CROHN’S DISEASE ASSOCIATES WITH ALTERED TRANSCRIPTION OF GENES INVOLVED IN VASCULAR REGULATION

IBD (Posters)  et al.

TELEMONITORING IBD WITH THE APP CARE4TODAY IBD: A REAL-LIFE CASE-CONTROL STUDY
TELEMONITORING IBD WITH THE APP CARE4TODAY IBD: A REAL-LIFE CASE-CONTROL STUDY

IBD (Posters)  et al.

VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS
VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

IBD (Posters)  et al.

IMPROVEMENT IN FATIGUE WITH MIRIKIZUMAB THERAPY IS ASSOCIATED WITH CLINICAL REMISSION AND PAIN IMPROVEMENTS BUT NOT WITH ENDOSCOPIC RESPONSE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
IMPROVEMENT IN FATIGUE WITH MIRIKIZUMAB THERAPY IS ASSOCIATED WITH CLINICAL REMISSION AND PAIN IMPROVEMENTS BUT NOT WITH ENDOSCOPIC RESPONSE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

IBD (Posters)  et al.

FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES
FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
MUCIN MRNA ISOFORM SIGNATURES AS POTENTIAL NOVEL BIOMARKERS TO EVALUATE DISEASE STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

POSTOPERATIVE IMMUNOSUPPRESSIVE THERAPY DOES NOT INFLUENCE ENDOSCOPIC RECURRENCE RATES AFTER BOWEL RESECTIONS DUE TO CROHN’S DISEASE – A RETROSPECTIVE MULTICENTRE ANALYSIS
POSTOPERATIVE IMMUNOSUPPRESSIVE THERAPY DOES NOT INFLUENCE ENDOSCOPIC RECURRENCE RATES AFTER BOWEL RESECTIONS DUE TO CROHN’S DISEASE – A RETROSPECTIVE MULTICENTRE ANALYSIS

IBD (Posters)  et al.

ACCUMULATION OF PRO-INFLAMMATORY CD4+ T CELLS AND ACTIVATED TCR VDELTA1+ T CELLS IN INFLAMED GUT TISSUE OF CROHN’S DISEASE PATIENTS
ACCUMULATION OF PRO-INFLAMMATORY CD4+ T CELLS AND ACTIVATED TCR VDELTA1+ T CELLS IN INFLAMED GUT TISSUE OF CROHN’S DISEASE PATIENTS

IBD (Posters)  et al.

INTERLEUKIN-23 AND INTERLEUKIN-12/23 INHIBITORS FOR THE TREATMENT OF CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
INTERLEUKIN-23 AND INTERLEUKIN-12/23 INHIBITORS FOR THE TREATMENT OF CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS

IBD (Posters)  et al.

Item 481 - 500 / 612
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
25
26 27 28 29 30 31